Search

Jeffrey E. Russel

Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809
Total Applications
3437
Issued Applications
2371
Pending Applications
237
Abandoned Applications
837

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 173538 [patent_doc_number] => 07658917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Modulators of amyloid aggregation' [patent_app_type] => utility [patent_app_number] => 10/463729 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 37841 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/658/07658917.pdf [firstpage_image] =>[orig_patent_app_number] => 10463729 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/463729
Modulators of amyloid aggregation Jun 16, 2003 Issued
Array ( [id] => 6925439 [patent_doc_number] => 20050238694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Satiety inducing composition' [patent_app_type] => utility [patent_app_number] => 10/519657 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7649 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238694.pdf [firstpage_image] =>[orig_patent_app_number] => 10519657 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/519657
Satiety inducing composition Jun 12, 2003 Issued
Array ( [id] => 7354774 [patent_doc_number] => 20040048783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Acidic insulin preparations having improved stability' [patent_app_type] => new [patent_app_number] => 10/461740 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4192 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048783.pdf [firstpage_image] =>[orig_patent_app_number] => 10461740 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/461740
Acidic insulin preparations having improved stability Jun 12, 2003 Abandoned
Array ( [id] => 296069 [patent_doc_number] => 07541339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Par-2-activating peptide derivative and pharmaceutical composition using the same' [patent_app_type] => utility [patent_app_number] => 10/517803 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4462 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541339.pdf [firstpage_image] =>[orig_patent_app_number] => 10517803 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/517803
Par-2-activating peptide derivative and pharmaceutical composition using the same Jun 9, 2003 Issued
Array ( [id] => 6805366 [patent_doc_number] => 20030232760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Conjugates useful in the treatment of prostate cancer' [patent_app_type] => new [patent_app_number] => 10/456342 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12466 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232760.pdf [firstpage_image] =>[orig_patent_app_number] => 10456342 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/456342
Conjugates useful in the treatment of prostate cancer Jun 5, 2003 Abandoned
Array ( [id] => 7270347 [patent_doc_number] => 20040058865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Homing peptide multimers, their preparation and uses' [patent_app_type] => new [patent_app_number] => 10/433212 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6606 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058865.pdf [firstpage_image] =>[orig_patent_app_number] => 10433212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/433212
Homing peptide multimers, their preparation and uses Jun 3, 2003 Abandoned
Array ( [id] => 7270339 [patent_doc_number] => 20040058857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Method of treating cancer' [patent_app_type] => new [patent_app_number] => 10/433596 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20340 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058857.pdf [firstpage_image] =>[orig_patent_app_number] => 10433596 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/433596
Method of treating cancer May 28, 2003 Abandoned
Array ( [id] => 5726303 [patent_doc_number] => 20060057063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Medicaments' [patent_app_type] => utility [patent_app_number] => 10/515248 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5842 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057063.pdf [firstpage_image] =>[orig_patent_app_number] => 10515248 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515248
Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent May 20, 2003 Issued
Array ( [id] => 728655 [patent_doc_number] => 07041649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Method for treating neurological conditions and inducing immunosuppression with cephaibols' [patent_app_type] => utility [patent_app_number] => 10/442848 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3383 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041649.pdf [firstpage_image] =>[orig_patent_app_number] => 10442848 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/442848
Method for treating neurological conditions and inducing immunosuppression with cephaibols May 20, 2003 Issued
Array ( [id] => 7367166 [patent_doc_number] => 20040006013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Histogranin peptide and their analgesic use' [patent_app_type] => new [patent_app_number] => 10/437435 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7724 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006013.pdf [firstpage_image] =>[orig_patent_app_number] => 10437435 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/437435
Histogranin peptides and their analgesic use May 13, 2003 Issued
Array ( [id] => 1037552 [patent_doc_number] => 06872701 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-29 [patent_title] => 'Glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 10/436341 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23183 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/872/06872701.pdf [firstpage_image] =>[orig_patent_app_number] => 10436341 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/436341
Glycopeptide phosphonate derivatives May 11, 2003 Issued
Array ( [id] => 7367027 [patent_doc_number] => 20040006000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Novel formulations' [patent_app_type] => new [patent_app_number] => 10/429508 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6255 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006000.pdf [firstpage_image] =>[orig_patent_app_number] => 10429508 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/429508
Novel formulations May 4, 2003 Abandoned
Array ( [id] => 658286 [patent_doc_number] => 07105482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Methionine aminopeptidase-2 inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/429174 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 17693 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105482.pdf [firstpage_image] =>[orig_patent_app_number] => 10429174 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/429174
Methionine aminopeptidase-2 inhibitors and methods of use thereof May 1, 2003 Issued
Array ( [id] => 975599 [patent_doc_number] => 06933275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-23 [patent_title] => 'Protein kinase C peptides for use in withdrawal' [patent_app_type] => utility [patent_app_number] => 10/428280 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 51 [patent_no_of_words] => 12928 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933275.pdf [firstpage_image] =>[orig_patent_app_number] => 10428280 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/428280
Protein kinase C peptides for use in withdrawal Apr 30, 2003 Issued
Array ( [id] => 690804 [patent_doc_number] => 07074765 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4' [patent_app_type] => utility [patent_app_number] => 10/426968 [patent_app_country] => US [patent_app_date] => 2003-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12380 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074765.pdf [firstpage_image] =>[orig_patent_app_number] => 10426968 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/426968
Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 Apr 30, 2003 Issued
Array ( [id] => 509621 [patent_doc_number] => 07199102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-03 [patent_title] => 'Orally administered peptides synergize statin activity' [patent_app_type] => utility [patent_app_number] => 10/423830 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25357 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/199/07199102.pdf [firstpage_image] =>[orig_patent_app_number] => 10423830 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/423830
Orally administered peptides synergize statin activity Apr 24, 2003 Issued
Array ( [id] => 7291812 [patent_doc_number] => 20040110928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Peptide conjugates for drug delivery' [patent_app_type] => new [patent_app_number] => 10/240430 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3766 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110928.pdf [firstpage_image] =>[orig_patent_app_number] => 10240430 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/240430
Peptide conjugates for drug delivery Apr 14, 2003 Abandoned
Array ( [id] => 6678878 [patent_doc_number] => 20030229019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/413160 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13389 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229019.pdf [firstpage_image] =>[orig_patent_app_number] => 10413160 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/413160
Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof Apr 13, 2003 Abandoned
Array ( [id] => 696108 [patent_doc_number] => 07071425 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Weighing machine having a central distributor to scales' [patent_app_type] => utility [patent_app_number] => 10/509815 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2153 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071425.pdf [firstpage_image] =>[orig_patent_app_number] => 10509815 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509815
Weighing machine having a central distributor to scales Apr 6, 2003 Issued
Array ( [id] => 6822094 [patent_doc_number] => 20030220255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'GLP-1 agonist and cardiovascular complications' [patent_app_type] => new [patent_app_number] => 10/406426 [patent_app_country] => US [patent_app_date] => 2003-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6079 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220255.pdf [firstpage_image] =>[orig_patent_app_number] => 10406426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/406426
GLP-1 agonist and cardiovascular complications Apr 2, 2003 Abandoned
Menu